CanSino Biologics Inc. (FRA:CJH)
Germany · Delayed Price · Currency is EUR 4.018
-0.132 (-3.18%)
Last updated: Jan 8, 2026, 3:29 PM CET
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of €1.52 billion as of January 9, 2026. Its market cap has increased by 4.11% in one year.
Market Cap
1.52B
Enterprise Value
1.36B
Revenue
116.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.02
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 859.40M to 1.52B, an increase of 77.34%. That is a compound annual growth rate of 8.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.52B | 10.26% |
| Dec 31, 2025 | 1.38B | -4.25% |
| Dec 31, 2024 | 1.44B | -0.39% |
| Dec 29, 2023 | 1.45B | -56.39% |
| Dec 30, 2022 | 3.32B | -55.43% |
| Dec 31, 2021 | 7.45B | -4.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 197.94B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.49B |
| Deutsche Bank Aktiengesellschaft | 63.01B |